Unlock instant, AI-driven research and patent intelligence for your innovation.

Imatinib intermediate and preparation method thereof

A technology for intermediates and compounds, applied in the pharmaceutical field, can solve problems such as large environmental pollution, and achieve the effects of simple and easy process conditions, mild process conditions, and easy realization.

Active Publication Date: 2016-06-08
NEW FOUNDER HLDG DEV LLC +3
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0020] The disadvantage of the above method is that highly toxic phosphorus oxychloride needs to be used after the cyclization, which causes great environmental pollution.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Imatinib intermediate and preparation method thereof
  • Imatinib intermediate and preparation method thereof
  • Imatinib intermediate and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0050] (2) Preparation method of imatinib intermediate V

[0051] The present invention secondly provides a method for preparing imatinib intermediate V as described in (1), said method comprising:

[0052] The following ring closure reaction occurs between the compound shown in formula III and the compound shown in formula IV under alkaline environment, so as to obtain the compound shown in formula V:

[0053]

[0054] Among them, R is selected from C 1 ~C 8 straight-chain or branched-chain alkanes, or benzyl.

[0055] Preferably, the molar ratio of the compound represented by formula III to the compound represented by formula IV is 1:(0.8-1.5), more preferably 1:(1.0-1.2). If the above-mentioned ratio is too low, the feeding amount of formula IV will be increased unnecessarily, which will not only increase the cost of preparing formula V, but also affect the purity of intermediate V; if the above-mentioned ratio is too high, the reaction of intermediate III will be inc...

Embodiment 1

[0082] Example 1: Preparation of the key intermediate 2-methoxy-4-(3-pyridyl)pyrimidine (Formula V):

[0083] Add 176g (1.00mol) of raw material III and 121.6g (1.10mol) of the hydrochloride salt of raw material IV whose R is a methyl group to 44g (1.1mol) of sodium hydroxide / 1000ml of methanol solution that has been stirred and dissolved, and heat up to reflux The reaction was carried out for 8 hours, and the reaction temperature was 65°C. After the reaction, desolvate under reduced pressure at 50°C (that is, remove the solvent, the same below), then add 400ml of dichloromethane and 400ml of pure water to dissolve, stir, extract and separate, and the organic layer is washed once with 400ml of pure water. 50 g of anhydrous sodium sulfate was dried for 1 hour, suction filtered, and the solvent was removed to obtain 173.7 g of a light yellow oily substance, namely 2-methoxy-4-(3-pyridyl)pyrimidine. The molar yield is 92.8%. HPLC purity was 98.72%.

[0084] The nuclear magneti...

Embodiment 2

[0085] Example 2: Preparation of the key intermediate 2-methoxy-4-(3-pyridyl)pyrimidine (Formula V):

[0086] Add 176g (1.00mol) of raw material III and 121.6g (1.10mol) of the hydrochloride salt of raw material IV whose R is a methyl group to the 44g (1.1mol) sodium hydroxide / 1000ml ethanol solution that has been stirred and dissolved, and heat up to reflux The reaction was carried out for 6 hours, and the reaction temperature was 77°C. After the reaction, desolvate under reduced pressure at 50°C, then add 400ml of dichloromethane and 400ml of pure water for dissolution, stirring, extraction, and liquid separation, and the organic layer is washed once with 400ml of pure water. 50 g of anhydrous sodium sulfate was dried for 1 hour, suction filtered, and the solvent was removed to obtain 172.1 g of light yellow oily substance, namely 2-methoxy-4-(3-pyridyl)pyrimidine. The molar yield is 91.9%, and the HPLC purity is 98.56%.

[0087] The NMR and mass spectrometry detection dat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Imatinib intermediates and a preparing method thereof are provided. The imatinib intermediates are compounds shown as a formula V, wherein R is selected from a C1-C8 straight-chain or branched-chain alkane, or benzyl. The imatinib intermediates (V) are prepared for the first time. Raw materials used in a preparation process are simple and easily available. Process conditions are mild, simple and feasible, and liable to achieve in production. A method of preparing imatinib through the imatinib intermediates (V) has characteristics of complete reaction, high yield, ideal purity of the imatinib, short technical process, capability of being not related to dangerous or highly toxic harmful compounds, few influences to the environment, and suitability for large-scale production.

Description

technical field [0001] The invention belongs to the field of pharmacy, and specifically relates to an imatinib intermediate V and a preparation method thereof, as well as a preparation method of imatinib. Background technique [0002] Imatinib was first developed by Novartis, Switzerland, and is the first tumor signal transduction inhibitor approved for marketing in the world. It is widely used clinically to treat chronic myelogenous leukemia. Its trade name is Gleevec, and it is now on the market in the United States, Europe, Japan and other countries, mostly in the form of its mesylate salt. [0003] The chemical name of imatinib is: 4-((4-methyl-1-piperazine)methyl)-N-(4-methyl-3-((4-(3-pyridine)-2-pyrimidine ) amino) phenyl) benzamide, the chemical formula is as shown in formula I: [0004] [0005] There are many patents on the preparation of imatinib, which can be roughly divided into the following routes: [0006] Route 1: The representative document is Chinese ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D401/04
CPCC07D401/04
Inventor 徐虹张铮王威
Owner NEW FOUNDER HLDG DEV LLC